ISU Abxis (Korea) Performance
| 086890 Stock | KRW 4,660 140.00 2.92% |
The company retains a Market Volatility (i.e., Beta) of 0.1, which attests to not very significant fluctuations relative to the market. As returns on the market increase, ISU Abxis' returns are expected to increase less than the market. However, during the bear market, the loss of holding ISU Abxis is expected to be smaller as well. At this point, ISU Abxis has a negative expected return of -0.44%. Please make sure to check out ISU Abxis' total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if ISU Abxis performance from the past will be repeated at some future point.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ISU Abxis Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -70.6 B |
ISU |
ISU Abxis Relative Risk vs. Return Landscape
If you would invest 624,000 in ISU Abxis Co on September 20, 2024 and sell it today you would lose (158,000) from holding ISU Abxis Co or give up 25.32% of portfolio value over 90 days. ISU Abxis Co is generating negative expected returns and assumes 2.5494% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than ISU, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ISU Abxis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ISU Abxis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ISU Abxis Co, and traders can use it to determine the average amount a ISU Abxis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1717
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 086890 |
Estimated Market Risk
| 2.55 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.44 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ISU Abxis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ISU Abxis by adding ISU Abxis to a well-diversified portfolio.
ISU Abxis Fundamentals Growth
ISU Stock prices reflect investors' perceptions of the future prospects and financial health of ISU Abxis, and ISU Abxis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ISU Stock performance.
| Return On Equity | 0.49 | |||
| Return On Asset | -0.0463 | |||
| Profit Margin | (0.57) % | |||
| Operating Margin | (0.30) % | |||
| Current Valuation | 365.33 B | |||
| Shares Outstanding | 26.63 M | |||
| Price To Sales | 5.25 X | |||
| Revenue | 28.02 B | |||
| EBITDA | (3.78 B) | |||
| Cash And Equivalents | 14.35 B | |||
| Cash Per Share | 326.65 X | |||
| Total Debt | 24.02 B | |||
| Debt To Equity | 2.60 % | |||
| Book Value Per Share | 2,322 X | |||
| Cash Flow From Operations | (5.84 B) | |||
| Total Asset | 151.09 B | |||
| Retained Earnings | (42.73 B) | |||
| Current Asset | 43.93 B | |||
| Current Liabilities | 14.95 B | |||
About ISU Abxis Performance
By analyzing ISU Abxis' fundamental ratios, stakeholders can gain valuable insights into ISU Abxis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ISU Abxis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ISU Abxis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ISU Abxis Co., Ltd., a biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide. ISU Abxis Co., Ltd. is headquartered in Seongnam, South Korea. ISU ABXIS is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about ISU Abxis performance evaluation
Checking the ongoing alerts about ISU Abxis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ISU Abxis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ISU Abxis generated a negative expected return over the last 90 days | |
| ISU Abxis Co has accumulated about 14.35 B in cash with (5.84 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 326.65. | |
| Roughly 34.0% of the company shares are owned by insiders or employees |
- Analyzing ISU Abxis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ISU Abxis' stock is overvalued or undervalued compared to its peers.
- Examining ISU Abxis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ISU Abxis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of ISU Abxis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ISU Abxis' stock. These opinions can provide insight into ISU Abxis' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ISU Stock analysis
When running ISU Abxis' price analysis, check to measure ISU Abxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISU Abxis is operating at the current time. Most of ISU Abxis' value examination focuses on studying past and present price action to predict the probability of ISU Abxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISU Abxis' price. Additionally, you may evaluate how the addition of ISU Abxis to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |